Estimating national-level measles case–fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study

[1]  M. Jit,et al.  Population-level risk factors related to measles case fatality: a conceptual framework and systematic review of evidence , 2022, medRxiv.

[2]  C. S. Wesseh,et al.  Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data , 2022, PLoS medicine.

[3]  P. Klepac,et al.  Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study , 2022, BMC Medicine.

[4]  N. Berhanu,et al.  Measles Outbreak Investigation in Guradamole District of Bale Zone, South Eastern Ethiopia, 2021 , 2022, Infection and drug resistance.

[5]  E. Mokaya,et al.  Measles outbreak investigation in Aweil East county, South Sudan , 2021, The Pan African medical journal.

[6]  J. H. Huber,et al.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world , 2021, eLife.

[7]  J. Alexander,et al.  Progress Toward Regional Measles Elimination — Worldwide, 2000–2019 , 2020, MMWR. Morbidity and mortality weekly report.

[8]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[9]  N. Walker,et al.  Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality , 2020, The Lancet.

[10]  Peng Zheng,et al.  Trimmed Constrained Mixed Effects Models: Formulations and Algorithms , 2019, bioRxiv.

[11]  M. Jit,et al.  Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis , 2019, The Lancet. Global health.

[12]  S. Deeks,et al.  Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. , 2018, Vaccine.

[13]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[14]  H. Whittle,et al.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy , 2012, BMJ Open.

[15]  Abhijeet Anand,et al.  Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data , 2012, The Lancet.

[16]  K. Wannemuehler,et al.  Changing epidemiology of measles in Africa. , 2011, The Journal of infectious diseases.

[17]  Hirotugu Akaike,et al.  Akaike's Information Criterion , 2011, International Encyclopedia of Statistical Science.

[18]  R. Grais,et al.  Estimates of measles case fatality ratios: a comprehensive review of community-based studies. , 2009, International journal of epidemiology.